CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Mateon Therapeutics Inc's Total Debt to Equity for Trailing Twelve Months Period

OXGN's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth



OXGN Total Debt to Equity for Trailing Twelve Months Period

(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Equity Growth 25955.92 % 3041.58 % - - -96.71 %
Y / Y Total Debt Growth - - - - -
Total Debt to Equity for Trailing Twelve Months Period 0.06 0.06 0.06 0.04 -
Total Ranking # 1173 # 1292 # 1332 # 1197 #
Seq. Equity Growth -10.59 % 252.09 % -14.53 % 9583.62 % -89.22 %
Seq. Total Debt Growth 16.39 % 109.74 % 97.56 % - -


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 16.39% Mateon Therapeutics Inc managed to unchange Total Debt to Equity for Trailing Twelve Months Period in I. Quarter to 0.06, below Mateon Therapeutics Inc's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 35 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Mateon Therapeutics Inc. While Total Debt to Equity for Trailing Twelve Months Period total ranking has improved so far to 1173, from total ranking in previous quarter at 1292.

What is Debt to Equity Ratio?
OXGN Charts and Quotes
Total Debt to Equity OXGN in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 36
Sector # 178
S&P 500 # 1171


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.06 0.06 0.04
(Mar 31 2020)   (Jun 30 2019)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Mar 31 2020, within Biotechnology & Drugs Industry Total Debt to Equity for Trailing Twelve Months Period
Heska Corp  0.17 
Azurrx Biopharma Inc   0.16 
Phathom Pharmaceuticals Inc   0.16 
Cellular Biomedicine Group Inc   0.15 
Vermillion Inc   0.15 
Windtree Therapeutics Inc  0.13 
Chromadex Corp   0.12 
Pdl Biopharma Inc   0.11 
Spark Therapeutics Inc   0.11 
Aclaris Therapeutics Inc   0.10 
Syndax Pharmaceuticals Inc  0.10 
Quidel Corp  0.09 
Gossamer Bio Inc   0.08 
Oncocyte Corp  0.07 
Mateon Therapeutics Inc  0.06 
Protagonist Therapeutics Inc   0.06 
Eidos Therapeutics Inc   0.05 
Oxford Immunotec Global Plc  0.04 
Satsuma Pharmaceuticals Inc   0.04 
Fate Therapeutics Inc  0.04 
Immunomedics Inc   0.04 
Cure Pharmaceutical Holding Corp   0.04 
Vericel Corporation  0.03 
Vaxart Inc   0.03 
Surface Oncology Inc   0.03 
Precipio Inc   0.03 
Renovacare Inc   0.03 
Champions Oncology Inc   0.02 
Zai Lab Limited  0.02 
Relmada Therapeutics Inc   0.02 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FAF's Profile

Stock Price

FAF's Financials

Business Description

Fundamentals

Charts & Quotes

FAF's News

Suppliers

FAF's Competitors

Customers & Markets

Economic Indicators

FAF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071